Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2024

  1. Clinical Perspectives, Eligibility, and Success Criteria for Bariatric/Metabolic Surgery

    Advances in experimental medicine and biology, Vol. 1460, pp. 677-695

  2. Epicardial and liver fat implications in albuminuria: a retrospective study

    Cardiovascular Diabetology, Vol. 23, Núm. 1

2022

  1. Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD

    Scientific Reports, Vol. 12, Núm. 1

  2. ‘Obesities’: Position statement on a complex disease entity with multifaceted drivers

    European Journal of Clinical Investigation, Vol. 52, Núm. 7

2021

  1. Diabetic kidney disease, cardiovascular disease and non-alcoholic fatty liver disease: A new triumvirate?

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  2. Role of ANGPTL8 in NAFLD improvement after bariatric surgery in experimental and human obesity

    International Journal of Molecular Sciences, Vol. 22, Núm. 23

2019

  1. Impact of nutritional changes on nonalcoholic fatty liver disease

    Nutrients, Vol. 11, Núm. 3

  2. Is pharmacotherapy enough for urgent weight loss in severely obese patients?

    Expert Opinion on Pharmacotherapy